Group Risk Development spokesperson Katharine Moxham talks to Corporate Adviser Editor John Greenwood about what the Prime Minister and the Work and Pensions Secretary of State’s comments about creating a private sickness benefit product could mean for the industry, and how it should respond.
Behind The Headlines – with Katharine Moxham
Corporate Adviser Special Report
Most Popular
-
SPP warns scale test could cause ‘industry paralysis’
-
L&G makes senior appointment within institutional retirement business
-
Majority of DB schemes to share surplus funds with employers only
-
Group risk benefits under pressure round table: Finding momentum in the protection market
-
Rachel Harris: CDC is a better fit for ‘paternalistic’ firms
-
Aegon’s Robinson joins Gallagher as head of DC investment
